Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cepheid

This article was originally published in The Gray Sheet

Executive Summary

Preliminary prospectus is filed with the SEC for an initial public offering valued at up to $92 mil. The Sunnyvale, California maker of microfluidic systems for detection and analysis of nucleic acids plans to launch its first product, the Smart Cycler DNA amplification and detection system for life sciences research, by July 1. The GeneXpert system in development "is designed to integrate automated sample preparation with our amplification and detection technology in a disposable cartridge format," Cepheid explains. "Our systems will allow practitioners in the life sciences research, clinical diagnostics, industrial testing and pharmacogenomics markets to make use of the vast new libraries of nucleic acid sequences now being generated by genomics researchers." Proceeds from the offering will be used for R&D, expansion of manufacturing and other general corporate purposes. As of March 31, the firm had an accumulated deficit of $15.8 mil. Warburg Dillon Read, Prudential Vector Healthcare and Invemed Associates are underwriters for the offering
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT013297

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel